GlassScriptPhysician profile
Shereen H Russell
NPI 1891878682
$3,515.91
in general payments reported to CMS, 2019-2025
17 companies · $78.42 in 2025
The $78.42 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,404 · 2020: $994 · 2021: $748 · 2022: $26.45 · 2023: $157 · 2024: $109 · 2025: $78.42.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $330 · Education: $13.35.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $330.33 |
| Education | $13.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celularity INC. | $2,419.00 | 2019-2021 | |
| Pfizer INC. | $375.44 | 2021-2024 | |
| Vertical Pharmaceuticals, LLC | $116.82 | 2019-2020 | |
| Astellas Pharma US INC | $107.01 | 2023-2025 | Veozah |
| Amag Pharmaceuticals, INC. | $72.25 | 2019-2020 | |
| Novo Nordisk INC | $68.45 | 2019-2020 | |
| Therapeuticsmd, INC. | $61.29 | 2019 | |
| Exeltis, USA INC. | $57.43 | 2019-2020 | |
| Mission Pharmacal Company | $44.88 | 2019 | |
| Allergan, INC. | $43.55 | 2019 | |
| Millicent US INC | $32.40 | 2019-2024 | |
| Ascend Therapeutics US, LLC | $24.38 | 2019 | |
| Abbvie INC. | $24.24 | 2019 | |
| Avion Pharmaceuticals | $21.92 | 2021 | |
| Roche Diagnostics Corporation | $19.19 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Renovia INC | $16.41 | 2019 | |
| Lupin INC. | $11.25 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shereen Russell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.